WHO ICTRP trial

Methoxyflurane efficacy and safety in hostile environment

EUCTR2017-004601-40-IT · EU Clinical Trials Register · Not Recruiting

Key facts

Trial ID EUCTR2017-004601-40-IT
Public title Methoxyflurane efficacy and safety in hostile environment
Scientific title Efficacy and safety of methoxyflurane in helicopter emergency medical system and hostile environment: a prospective, multicentre clinical trial - METEORA
Primary sponsor MUNDIPHARMA RESEARCH LIMITED
Registry EU Clinical Trials Register
Recruitment status Not Recruiting
Study type Interventional clinical trial of medicinal product
Phase Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): no
Countries Italy
Conditions moderate to severe pain secondary to minor trauma MedDRA version: 21.1 Level: PT Classification code 10072132 Term: Fracture pain System Organ Class: 10028395 - Musculoskeletal and connective tissue disorders ;Therapeutic area: Diseases [C]…
Interventions Trade Name: Penthrox® Product Name: metossiflurano vaporizzato Product Code: [metossiflurano vaporizzato] Pharmaceutical Form: Nebuliser solution INN or Proposed INN: Methoxyflurane CAS Number: 76-38-0 Current Sponsor code: MR 311-3505…
Registration date May 24, 2021
Target size 200
Secondary IDs MR311-3505;MR 311-3505
Registry page clinicaltrialsregister.eu

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations